Theradigm-HBV
a lipopeptide-based vaccine used in treatment of chronic hepatitis B virus (HBV) infection; has 3 components, HBV core antigen peptide (18-27) as the CTL epitope, tetanus toxoid peptide 830-843 as the T helper peptide, and two palmitive acid molecules; structure given in first source
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results